Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Acquired Approval for Manufacturing and Marketing Generic Drugs
Details : Loxoprofen Sodium is a generic version of loxonin tape, which is indicated for the treatment of rheumatoid arthritis and osteoarthritis.
Product Name : Loxoprofen Sodium Tape
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 15, 2024
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers
Details : Loxoprofen Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Osteoarthritis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 19, 2024
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : SSP Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Loxoprofen is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 13, 2016
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : SSP Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Cardinal Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Loxoprofen is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Muscle Fatigue.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 11, 2015
Lead Product(s) : Loxoprofen Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Cardinal Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
